Purchases and Sales Made in Q2 2024 in Xtl Biopharmaceuticals LTD (XTLB)
This table provides information about the institutional ownership of Xtl Biopharmaceuticals LTD (XTLB) during Q2 2024. The information is specifically focused on institutions that hold shares of XTL BIOPHARMACEUTICALS LTD.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
5.58KNew |
$11.4K - $18.6K
|
5.58K
$10.3K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
1.8K+ 13.23% |
$3.68K - $6.01K
|
15.4K
$28.6K
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6.02K- 15.37% |
$12.3K - $20K
|
33.2K
$61.3K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6.02K- 15.37% |
$12.3K - $20K
|
33.2K
$61.3K
|